Pishesha N, Harmand TJ, Ploegh HL. A guide to antigen processing and presentation. Nat Rev Immunol. 2022;22:751–64.

Article  PubMed  CAS  Google Scholar 

Wong-Benito V, de Rijke J, Dixon B. Antigen presentation in vertebrates: structural and functional aspects. Dev Comp Immunol. 2023;144:104702.

Article  PubMed  CAS  Google Scholar 

Blees A, Januliene D, Hofmann T, Koller N, Schmidt C, Trowitzsch S, Moeller A, Tampe R. Structure of the human MHC-I peptide-loading complex. Nature. 2017;551:525–8.

Article  PubMed  CAS  Google Scholar 

Rock KL, Reits E, Neefjes J. Present yourself! By MHC class I and MHC class II molecules. Trends Immunol. 2016;37:724–37.

Article  PubMed  PubMed Central  CAS  Google Scholar 

van Hateren A, Elliott T. The role of MHC I protein dynamics in tapasin and TAPBPR-assisted immunopeptidome editing. Curr Opin Immunol. 2021;70:138–43.

Article  PubMed  Google Scholar 

Sykulev Y. Factors contributing to the potency of CD8(+) T cells. Trends Immunol 2023.

Yamamoto K, Venida A, Yano J, Biancur DE, Kakiuchi M, Gupta S, Sohn ASW, Mukhopadhyay S, Lin EY, Parker SJ, et al. Autophagy promotes immune evasion of Pancreatic cancer by degrading MHC-I. Nature. 2020;581:100–5.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Dhatchinamoorthy K, Colbert JD, Rock KL. Cancer Immune Evasion through loss of MHC Class I Antigen Presentation. Front Immunol. 2021;12:636568.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Flajnik MF, Kasahara M. Origin and evolution of the adaptive immune system: genetic events and selective pressures. Nat Rev Genet. 2010;11:47–59.

Article  PubMed  CAS  Google Scholar 

Creech AL, Ting YS, Goulding SP, Sauld JFK, Barthelme D, Rooney MS, Addona TA, Abelin JG. The role of Mass Spectrometry and Proteogenomics in the Advancement of HLA Epitope Prediction. Proteomics. 2018;18:e1700259.

Article  PubMed  Google Scholar 

Murali-Krishna K, Lau LL, Sambhara S, Lemonnier F, Altman J, Ahmed R. Persistence of memory CD8 T cells in MHC class I-deficient mice. Science. 1999;286:1377–81.

Article  PubMed  CAS  Google Scholar 

Benko S, Kovacs EG, Hezel F, Kufer TA. NLRC5 functions beyond MHC I regulation-what do we know so far? Front Immunol. 2017;8:150.

Article  PubMed  PubMed Central  Google Scholar 

Neerincx A, Lautz K, Menning M, Kremmer E, Zigrino P, Hosel M, Buning H, Schwarzenbacher R, Kufer TA. A role for the human nucleotide-binding domain, leucine-rich repeat-containing family member NLRC5 in antiviral responses. J Biol Chem. 2010;285:26223–32.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Benci JL, Johnson LR, Choa R, Xu Y, Qiu J, Zhou Z, Xu B, Ye D, Nathanson KL, June CH, et al. Opposing functions of Interferon Coordinate Adaptive and Innate Immune responses to Cancer Immune Checkpoint Blockade. Cell. 2019;178:933–948e914.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Chen X, Lu Q, Zhou H, Liu J, Nadorp B, Lasry A, Sun Z, Lai B, Rona G, Zhang J et al. A membrane-associated MHC-I inhibitory axis for cancer immune evasion. Cell 2023.

Luo N, Nixon MJ, Gonzalez-Ericsson PI, Sanchez V, Opalenik SR, Li H, Zahnow CA, Nickels ML, Liu F, Tantawy MN, et al. DNA methyltransferase inhibition upregulates MHC-I to potentiate cytotoxic T lymphocyte responses in Breast cancer. Nat Commun. 2018;9:248.

Article  PubMed  PubMed Central  Google Scholar 

Ren J, Li N, Pei S, Lian Y, Li L, Peng Y, Liu Q, Guo J, Wang X, Han Y et al. Histone methyltransferase WHSC1 loss dampens MHC-I antigen presentation pathway to impair IFN-gamma-stimulated antitumor immunity. J Clin Invest 2022, 132.

Sun T, Li Y, Yang W, Wu H, Li X, Huang Y, Zhou Y, Du Z. Histone deacetylase inhibition up-regulates MHC class I to facilitate cytotoxic T lymphocyte-mediated Tumor cell killing in glioma cells. J Cancer. 2019;10:5638–45.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Hu Y, Pei W, Hu Y, Li P, Sun C, Du J, Zhang Y, Miao F, Zhang A, Shen Y, Zhang J. MiR34a regulates neuronal MHC class I molecules and promotes primary hippocampal neuron dendritic growth and branching. Front Cell Neurosci. 2020;14:573208.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Zheng J, Yang T, Gao S, Cheng M, Shao Y, Xi Y, Guo L, Zhang D, Gao W, Zhang G, et al. miR-148a-3p silences the CANX/MHC-I pathway and impairs CD8(+) T cell-mediated immune Attack in Colorectal cancer. FASEB J. 2021;35:e21776.

Article  PubMed  CAS  Google Scholar 

Mari L, Hoefnagel SJM, Zito D, van de Meent M, van Endert P, Calpe S, Sancho Serra MDC, Heemskerk MHM, van Laarhoven HWM, Hulshof M, et al. microRNA 125a regulates MHC-I expression on Esophageal Adenocarcinoma Cells, Associated with suppression of Antitumor Immune response and poor outcomes of patients. Gastroenterology. 2018;155:784–98.

Article  PubMed  CAS  Google Scholar 

Jhunjhunwala S, Hammer C, Delamarre L. Antigen presentation in cancer: insights into tumour immunogenicity and immune evasion. Nat Rev Cancer. 2021;21:298–312.

Article  PubMed  CAS  Google Scholar 

Dersh D, Holly J, Yewdell JW. A few good peptides: MHC class I-based cancer immunosurveillance and immunoevasion. Nat Rev Immunol. 2021;21:116–28.

Article  PubMed  CAS  Google Scholar 

Jongsma MLM, de Waard AA, Raaben M, Zhang T, Cabukusta B, Platzer R, Blomen VA, Xagara A, Verkerk T, Bliss S, et al. The SPPL3-Defined glycosphingolipid repertoire orchestrates HLA class I-Mediated Immune responses. Immunity. 2021;54:132–150e139.

Article  PubMed  CAS  Google Scholar 

Ito Y, Pan D, Zhang W, Zhang X, Juan TY, Pyrdol JW, Kyrysyuk O, Doench JG, Liu XS, Wucherpfennig KW. Addressing Tumor heterogeneity by sensitizing resistant Cancer cells to T cell-secreted cytokines. Cancer Discov. 2023;13:1186–209.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Westrich JA, Vermeer DW, Silva A, Bonney S, Berger JN, Cicchini L, Greer RO, Song JI, Raben D, Slansky JE, et al. CXCL14 suppresses human papillomavirus-associated Head and Neck cancer through antigen-specific CD8(+) T-cell responses by upregulating MHC-I expression. Oncogene. 2019;38:7166–80.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Andre P, Denis C, Soulas C, Bourbon-Caillet C, Lopez J, Arnoux T, Blery M, Bonnafous C, Gauthier L, Morel A, et al. Anti-NKG2A mAb is a checkpoint inhibitor that promotes anti-tumor immunity by unleashing both T and NK Cells. Cell. 2018;175:1731–1743e1713.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Abd Hamid M, Wang RZ, Yao X, Fan P, Li X, Chang XM, Feng Y, Jones S, Maldonado-Perez D, Waugh C, et al. Enriched HLA-E and CD94/NKG2A Interaction limits Antitumor CD8(+) tumor-infiltrating T lymphocyte responses. Cancer Immunol Res. 2019;7:1293–306.

Article  PubMed  Google Scholar 

van Montfoort N, Borst L, Korrer MJ, Sluijter M, Marijt KA, Santegoets SJ, van Ham VJ, Ehsan I, Charoentong P, Andre P, et al. NKG2A Blockade Potentiates CD8 T Cell Immunity Induced by Cancer vaccines. Cell. 2018;175:1744–1755e1715.

Article  PubMed  PubMed Central  Google Scholar 

Lerner EC, Woroniecka KI, D’Anniballe VM, Wilkinson DS, Mohan AA, Lorrey SJ, Waibl-Polania J, Wachsmuth LP, Miggelbrink AM, Jackson JD et al. CD8(+) T cells maintain killing of MHC-I-negative Tumor cells through the NKG2D-NKG2DL axis. Nat Cancer 2023.

Eugene J, Jouand N, Ducoin K, Dansette D, Oger R, Deleine C, Leveque E, Meurette G, Podevin J, Matysiak T, et al. The inhibitory receptor CD94/NKG2A on CD8(+) tumor-infiltrating lymphocytes in Colorectal cancer: a promising new druggable immune checkpoint in the context of HLAE/beta2m overexpression. Mod Pathol. 2020;33:468–82.

Article  PubMed  CAS  Google Scholar 

Liu X, Song J, Zhang H, Liu X, Zuo F, Zhao Y, Zhao Y, Yin X, Guo X, Wu X, et al. Immune checkpoint HLA-E:CD94-NKG2A mediates evasion of circulating Tumor cells from NK cell surveillance. Cancer Cell. 2023;41:272–287e279.

Article  PubMed  CAS  Google Scholar 

Krijgsman D, Roelands J, Hendrickx W, Bedognetti D, Kuppen PJK. HLA-G: a New Immune Checkpoint in Cancer? Int J Mol Sci 2020, 21.

Wolf NK, Kissiov DU, Raulet DH. Roles of natural killer cells in immunity to cancer, and applications to immunotherapy. Nat Rev Immunol. 2023;23:90–105.

Article  PubMed  CAS  Google Scholar 

Ferrari de Andrade L, Tay RE, Pan D, Luoma AM, Ito Y, Badrinath S, Tsoucas D, Franz B, May KF Jr., Harvey CJ, et al. Antibody-mediated inhibition of MICA and MICB shedding promotes NK cell-driven Tumor immunity. Science. 2018;359:1537–42.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Ardolino M, Azimi CS, Iannello A, Trevino TN, Horan L, Zhang L, Deng W, Ring AM, Fischer S, Garcia KC, Raulet DH. Cytokine therapy reverses NK cell anergy in MHC-deficient tumors. J Clin Invest. 2014;124:4781–94.

Article  PubMed  PubMed Central  Google Scholar 

Neo SY, Jing X, Tong L, Tong D, Gao J, Chen Z, De Los Santos MC, Burduli N, De Souza Ferreira S, Wagner AK et al. Tumor MHC class I expression alters cancer-associated myelopoiesis driven by host NK cells. J Immunother Cancer 2022, 10.

Marchesi M, Andersson E, Villabona L, Seliger B, Lundqvist A, Kiessling R, Masucci GV. HLA-dependent tumour development: a role for tumour associate macrophages? J Transl Med. 2013;11:247.

Article  PubMed  PubMed Central  Google Scholar